RCM
EIDX
RA Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,163,271
| Closed | -$109M | – | 90 |
|
|
2020
Q3 | $109M | Buy |
2,163,271
+600
| +0% | +$30.3K | 2% | 14 |
|
|
2020
Q2 | $103M | Hold |
2,162,671
| – | – | 2.01% | 18 |
|
|
2020
Q1 | $106M | Hold |
2,162,671
| – | – | 3.35% | 7 |
|
|
2019
Q4 | $124M | Hold |
2,162,671
| – | – | 3.76% | 7 |
|
|
2019
Q3 | $77.8M | Hold |
2,162,671
| – | – | 4.63% | 6 |
|
|
2019
Q2 | $113M | Hold |
2,162,671
| – | – | 6.05% | 6 |
|
|
2019
Q1 | $91.1M | Hold |
2,162,671
| – | – | 3.93% | 8 |
|
|
2018
Q4 | $59.2M | Hold |
2,162,671
| – | – | 3.45% | 10 |
|
|
2018
Q3 | $21.6M | Hold |
2,162,671
| – | – | 1.15% | 19 |
|
|
2018
Q2 | $44M | Buy |
+2,162,671
| New | +$44M | 2.86% | 14 |
|